Vifor Pharma in US$100m licence deal with Cara TherapeuticsVifor Pharma and Cara Therapeutics have signed a US license agreement for Korsuva to treat dialysis patients with pruritus. more ➔
Atriva Therapeutics gets €24m from EIB Atriva Therapeutics has secured a €24m loan to push the development of its COVID-19 programme ATR-002, an antiviral, anti-inflammatory MEK inhibitor. more ➔
Topas raises €22m in Series B financiningTopas Therapeutics GmbH will use the €22m proceeds from a Series B Financing to advance two pipeline candidates. more ➔
Siemens launches COVID-19 antigen lateral flow testSiemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes. more ➔
Priothera closes €30m Series A financingPriothera Ltd. wants to use €30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML). more ➔
COVID-19 jab: EU signs contract with JNJJohnson & Johnson (JNJ) has inked a contract with the European Commission to supply 200 million doses of its COVID-19 vaccine to the European Union. more ➔
Santhera ends development of idebenoneSwiss Santhera Pharmaceuticals has discontinued Phase III development of its DMD drug and will restructure its pipeline. more ➔
Nobel Prize in Physiology for HCV pioneersThe Nobel Prize in Physiology or Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Ric more ➔
Swiss Sophia Genetics to expand globallySwiss Sophia Genetics has raised $110m, to expand marketing of its AI-driven cancer and genetic disease decision support platform globally. more ➔
EIB and EC launch circular bioeconomy fundThe European Commission (EC) and the European Investment Bank (EIB) have launched a circular bioeconomy fund with a target size of €250m. more ➔ · more ➔
